-17%

NEW

GLOW 70 mg

Original price was: 179,99 €.Current price is: 149,99 €. with VAT

GLOW is a premixed blend of three regenerative peptides in a single vial— 10 mg of BPC-157 + 10 mg of TB-500 + 50 mg of GHK-Cu. Three complementary mechanisms: BPC-157 promotes local healing via the FAK-paxillin pathway; TB-500 facilitates systemic mobilization of repair cells; and GHK-Cu supports collagen synthesis and extracellular matrix remodeling.

Purity ≥ 98% – Each batch verified by HPLC; COA available upon request
70 mg of lyophilized powder, −20 °C | after reconstitution (0.9% NaCl) 2–8 °C for up to 28 days
Shipped within 48 hours

In stock

Dosage calculator

Quantity discount

Quantity	Price	% Discount
7+	134,99 €	10%
4+	142,49 €	5%

Category: Research on Tissue Regeneration and Healing

All products are sold exclusively for the purpose of scientific research and development.
The chemical substances may not be used as a medicine, drug, active substance, medical device, cosmetic product, substance for the manufacture of a cosmetic product, or as a substance for human consumption, i.e. as a food or nutritional supplement, or in any other similar way on humans or animals.

All customers MUST be at least 18 years of age to purchase our products.

Laboratory-tested

Fast and Discreet Shipping

Purity Guarantee

98%+

Description

GLOW 70 mg – Tripeptide Research Blend (BPC-157 · TB-500 · GHK-Cu)

⚠️ Warning: This product is intended exclusively for scientific research and laboratory use in accordance with EU chemical legislation. It is not intended for human or veterinary consumption, nor for the diagnosis, treatment, or prevention of any diseases. Sale restricted to individuals over the age of 18.
GLOW is a freeze-dried research blend consisting of three synthetic peptides with a well-documented preclinical profile: BPC-157 (10 mg), TB-500 / Thymosin Beta-4 (10 mg), and GHK-Cu / Copper Peptide (50 mg). The combination was designed to enable the simultaneous study of multiple molecular pathways involved in tissue healing, cell regeneration, and extracellular matrix synthesis.

Composition and CAS Numbers

Ingredient	Quantity	CAS Number	Form
BPC-157 (Body Protection Compound)	10 mg	137525-51-0	lyophilized powder
TB-500 (Thymosin Beta-4)	10 mg	77591-33-4	lyophilized powder
GHK-Cu (Copper Tripeptide-1)	50 mg	89030-95-5	lyophilized powder
Total amount	70 mg	—	—

Research Profile of the Components

BPC-157 (Body Protection Compound 157) — 10 mg

BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids, derived from the BPC protein isolated from human gastric juice. In preclinical studies using animal models, it has been investigated for its potential to modulate tissue healing processes through multiple signaling cascades.
Research mechanisms (preclinical data):

Activation of the FAK-paxillin signaling pathway → promotion of cell migration and proliferation
Modulation of Nitric Oxide (NO) Synthase Expression
Stimulation of angiogenesis via the VEGF pathway
Anti-inflammatory effects in models of inflammatory bowel disease (IBD)

Areas of preclinical research: healing of tendons and ligaments, gastrointestinal protection, neuroprotection, cardioprotection.

TB-500 / Thymosin Beta-4 — 10 mg

Thymosin Beta-4 (Tβ4) is a naturally occurring peptide composed of 43 amino acids, released by platelets and macrophages at sites of injury. TB-500 is a synthetic version of it. Unlike BPC-157, it acts primarily systemically—by regulating the actin cytoskeleton and stem cell migration.
Research mechanisms (preclinical data):

Binding to G-actin → regulation of actin filament polymerization
Promotion of the migration of stem cells and progenitor cells to the site of injury
Reducing Apoptosis and the Inflammatory Response in Injured Tissue
Preclinical research on cardioprotective properties (independent of the GH axis)

Areas of preclinical research: muscle and tendon regeneration, wound healing, cardiac regeneration, neuroprotection.

GHK-Cu / Copper Tripeptide-1 — 50 mg

GHK-Cu (glycyl-L-histidyl-L-lysine + Cu²⁺) is a naturally occurring tripeptide with a high affinity for copper ions (Cu²⁺). It has been extensively studied for its role in the regulation of the extracellular matrix, collagen synthesis, and tissue healing. Its highest concentration in the GLOW blends (50 mg) reflects its unique research potential.
Research mechanisms (preclinical data):

Stimulation of collagen I, III, and elastin synthesis in dermatological cell models
Activation of MMPs (matrix metalloproteinases) → remodeling of the extracellular matrix
Stimulation of blood vessel growth (angiogenesis) and nerve fiber growth (neurite formation)
Modulation of inflammatory cytokines (TNF-α, IL-1β, IL-6) in vitro
Activation of genes associated with DNA repair

Areas of preclinical research: skin and connective tissue regeneration, collagen synthesis, wound healing, neuroprotection, and anti-aging research using cellular models.

Scientific Synergy of the Three Components

From a research perspective, the combination of BPC-157, TB-500, and GHK-Cu is particularly interesting because of the complementary nature of their mechanisms of action:

BPC-157 acts primarily at the local level and promotes the healing of specific tissues (tendons, ligaments, GI mucosa) through the FAK and NO pathways
TB-500 provides a systemic component—the mobilization of repair cells and the regulation of actin across tissues
GHK-Cu contributes to the research model through its unique ability to stimulate collagen synthesis and remodel the extracellular matrix, thereby creating the structural foundation for tissue regeneration

This trio covers three distinct but complementary aspects of tissue biology: healing signaling (BPC-157) → mobilization of repair cells (TB-500) → matrix synthesis (GHK-Cu). It is precisely this synergy that makes GLOW blends an interesting subject for further preclinical research.

Technical Specifications

Parameter	Value
Total amount	70 mg (10/10/50)
Form	Freeze-dried powder (vial)
Purity	≥98% (HPLC-verified)
Recommended solvent	0.9% NaCl saline solution
Storage – freeze-dried	−20 °C, protect from light
Storage – after reconstitution	2–8 °C, use within 28 days
Intended Use	Exclusively preclinical/laboratory research
Age Restriction	18+

Why GLOW blend?

Three peptides in one vial — reduces handling and simplifies the research protocol
The 10/10/50 mg ratio — reflects research data on the dosages of the individual ingredients
Purity ≥98% — verified by HPLC analysis; each batch tested
Freeze-dried form — maximum storage stability, longer shelf life

Frequently Asked Questions About GLOW 70 mg (FAQ)

What is GLOW 70 mg?

GLOW 70 mg is a lyophilized research blend of three synthetic peptides—BPC-157 (10 mg), TB-500 (10 mg), and GHK-Cu (50 mg) — intended exclusively for preclinical research under laboratory conditions.

Why 0.9% NaCl and not bacteriostatic water?

We recommend 0.9% NaCl saline solution as the standard laboratory solvent for this blend. Bacteriostatic water is also suitable for long-term storage of the reconstituted sample—depending on the specific research protocol. Use the dosing calculator to calculate the exact volume.

What is the purity of the product?

The purity of each component is ≥98%, as verified by HPLC (high-performance liquid chromatography).

How should GLOW 70 mg be stored before reconstitution?

Store the freeze-dried vial at −20 °C, protected from light and moisture. After reconstitution, store at 2–8 °C.

Is GLOW 70 mg intended for human use?

No. This product is intended solely for scientific research and laboratory use. It is not intended for human or veterinary use.

⚠️ Final Disclaimer

All information provided in this description is intended solely for scientific and research purposes. We do not provide any clinical recommendations. GLOW 70 mg is not a drug, a dietary supplement, or a cosmetic product. It has not been approved by any regulatory authority (EMA, ŠÚKL) for human use. The seller is not liable for any use of the product that violates these terms and conditions.